Ultrasonography Fusion Imaging System Increases the Chance of Radiofrequency Ablation for Hepatocellular Carcinoma with Poor Conspicuity on Conventional Ultrasonography

Objectives: To investigate the usefulness of the ultrasonography (US) fusion imaging system for radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). Methods: Since the US fusion imaging system became available in 2010, we have conducted RFA with this system in all cases. The characteristics of 75 patients with 120 HCCs and 89 patients with 123 HCCs who underwent RFA before the introduction of this system (period A) and after it (period B), respectively, were retrospectively compared. Results: Significant difference in the characteristics of the patients and HCCs between the two periods was found only in the proportion of HCCs with poor conspicuity on grayscale US treated with RFA (1.7%, 2/120 for period A vs. 15.4%, 19/123 for period B, p < 0.01). Among the 19 HCCs with poor conspicuity on grayscale US for period B, 5 and 9 HCCs were identified on grayscale US and contrast-enhanced US, respectively, by the use of the US fusion imaging system, whereas the 5 remaining undetectable HCCs were treated by using the system in conjunction with reference images displayed side-by-side with grayscale US. Conclusion: Since the introduction of the US fusion imaging system, it has become possible to perform RFA for HCCs with poor conspicuity on grayscale US.

[1]  C. Catalano,et al.  Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis. , 2010, Radiology.

[2]  Rita Golfieri,et al.  Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤2 cm) HCC in cirrhosis , 2011, European Radiology.

[3]  S. Kumano,et al.  Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT , 2012, Journal of Gastroenterology.

[4]  Jung Wook Seo,et al.  Planning ultrasound for percutaneous radiofrequency ablation to treat small (≤ 3 cm) hepatocellular carcinomas detected on computed tomography or magnetic resonance imaging: a multicenter prospective study to assess factors affecting ultrasound visibility. , 2012, Journal of vascular and interventional radiology : JVIR.

[5]  U. Motosugi,et al.  Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. , 2011, Radiology.

[6]  R. Lencioni,et al.  Local-regional treatment of hepatocellular carcinoma. , 2012, Radiology.

[7]  J. Shindoh,et al.  Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma. , 2011, AJR. American journal of roentgenology.

[8]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[9]  M. Kudo,et al.  Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm. , 2010, World journal of gastroenterology.

[10]  Young Jun Kim,et al.  Targeted sonography for small hepatocellular carcinoma discovered by CT or MRI: factors affecting sonographic detection. , 2010, AJR. American journal of roentgenology.

[11]  Riccardo Lencioni,et al.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. , 2012, Journal of hepatology.

[12]  L. Bolondi,et al.  Comparison of International Guidelines for Noninvasive Diagnosis of Hepatocellular Carcinoma , 2012, Liver Cancer.

[13]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[14]  Morio Sato,et al.  Radiofrequency Ablation Assisted by Real-Time Virtual Sonography and CT for Hepatocellular Carcinoma Undetectable by Conventional Sonography , 2008, CardioVascular and Interventional Radiology.

[15]  R. Andersson,et al.  Radiofrequency ablation or percutaneous ethanol injection for the treatment of liver tumors. , 2012, World journal of gastroenterology.

[16]  Michiie Sakamoto,et al.  Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia , 2009, Hepatology.

[17]  Young Jun Kim,et al.  Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. , 2012, AJR. American journal of roentgenology.

[18]  V. Mazzaferro,et al.  EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer , 2012 .

[19]  M. Lee,et al.  Small hepatocellular carcinomas: ultrasonography guided percutaneous radiofrequency ablation , 2013, Abdominal Imaging.

[20]  T. Murakami,et al.  Ultrasonography, Computed Tomography and Magnetic Resonance Imaging of Hepatocellular Carcinoma: Toward Improved Treatment Decisions , 2011, Oncology.

[21]  Y. Imai,et al.  Relation of Interferon Therapy and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C , 1998, Annals of Internal Medicine.

[22]  S. Kumano,et al.  Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT , 2012, European Radiology.

[23]  T. Murakami,et al.  Superparamagnetic iron oxide–enhanced magnetic resonance images of hepatocellular carcinoma: Correlation with histological grading , 2000, Hepatology.

[24]  M. Kudo,et al.  Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma. , 2011, World journal of gastroenterology.

[25]  Ijin Joo,et al.  Recent Advances in CT and MR Imaging for Evaluation of Hepatocellular Carcinoma , 2012, Liver Cancer.

[26]  Kinuyo Hatanaka,et al.  Double-Contrast Ultrasound: A Novel Surveillance Tool for Hepatocellular Carcinoma , 2011, The American Journal of Gastroenterology.

[27]  M. Dumont,et al.  European Association for the Study of the Liver , 1971 .

[28]  Hui-Xiong Xu,et al.  Detection of focal liver lesions in cirrhotic liver using contrast-enhanced ultrasound. , 2009, World journal of radiology.

[29]  Takamichi Murakami,et al.  Usefulness of the Multimodality Fusion Imaging for the Diagnosis and Treatment of Hepatocellular Carcinoma , 2012, Digestive Diseases.

[30]  M. Morimoto,et al.  Contrast enhanced ultrasound of hepatocellular carcinoma. , 2010, World journal of radiology.

[31]  P. Rosenthal,et al.  American Association for the Study of Liver Diseases , 1993, IDrugs : the investigational drugs journal.

[32]  T. Arima,et al.  Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation , 2003, Cancer.

[33]  J. Ricke,et al.  Noninvasive Diagnosis of Hepatocellular Carcinoma in Cirrhotic Liver: Current Guidelines and Future Prospects for Radiological Imaging , 2012, Liver Cancer.

[34]  Masahiro Okada,et al.  Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow , 2010, European Radiology.

[35]  Masahiro Okada,et al.  Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma. , 2012, AJR. American journal of roentgenology.

[36]  M. Makuuchi,et al.  Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version , 2011, Digestive Diseases.